Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8072)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 10, 2018 (publication date) through Oct 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Uchida J, Iwai T, Nakatani T. Introduction of everolimus in kidney transplant recipients at a late posttransplant stage. World J Transplantation 2018; 8(5): 150-155 [PMID: 30211023 DOI: 10.5500/wjt.v8.i5.150] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v8/i5/150.htm |
| Number | Citing Articles |
| 1 |
Kun-Che Chang, Pei-Feng Liu, Chia-Hsuan Chang, Ying-Cheng Lin, Yen-Ju Chen, Chih-Wen Shu. The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-021-00736-9
|
| 2 |
Stephan Klöß, Susann Dehmel, Armin Braun, Michael J. Parnham, Ulrike Köhl, Susanne Schiffmann. From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01423
|
| 3 |
Oleksandr Kirsanov, Randall H Renegar, Jonathan T Busada, Nicholas D Serra, Ellen V Harrington, Taylor A Johnson, Christopher B Geyer. The rapamycin analog Everolimus reversibly impairs male germ cell differentiation and fertility in the mouse†. Biology of Reproduction 2020; 103(5): 1132 doi: 10.1093/biolre/ioaa130
|
| 4 |
Majda Sahman, Snezana Mugosa, Nemanja Rancic. Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study. Frontiers in Public Health 2021; 9 doi: 10.3389/fpubh.2021.671316
|
| 5 |
Naomi Hayase, Mariko Yamada, Shuhei Kaneko, Yoko Watanabe. Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan. Clinical and Experimental Nephrology 2021; 25(6): 660 doi: 10.1007/s10157-021-02024-9
|
| 6 |
B.P.S. Assis, M.F. Lasmar, R.A. Fabreti-Oliveira, S.A. Araujo, J. Oliveira, D.C. Wanderley, E. Nascimento. An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients. Brazilian Journal of Medical and Biological Research 2021; 54(4) doi: 10.1590/1414-431x20209369
|
| 7 |
Lee S. Nguyen, Gaspard Suc, Vissal David Kheav, Guillaume Coutance, Maryvonnick Carmagnat, Philippe Rouvier, Noel Zahr, Joe-Elie Salem, Pascal Leprince, Salima Ouldammar, Shaida Varnous. Quadritherapy vs standard tritherapy immunosuppressant regimen after heart transplantation: A propensity score–matched cohort analysis. American Journal of Transplantation 2020; 20(10): 2791 doi: 10.1111/ajt.15849
|